| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/20/2000 | CA2320697A1 Oligonucleotide mediated nucleic acid recombination |
| 07/20/2000 | CA2259830A1 Ras activator nucleic acid molecules, proteins and methods of use |
| 07/19/2000 | EP1020534A1 Process for synthesizing nucleic acid |
| 07/19/2000 | EP1020529A2 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| 07/19/2000 | EP1020528A2 Method for producing secreted proteins |
| 07/19/2000 | EP1020527A1 Mutated barnase gene and plant transformed by the same |
| 07/19/2000 | EP1020526A2 Process for producing L-Threonine by fermentation |
| 07/19/2000 | EP1020525A1 Novel protoporphyrinogen oxidase tolerant to light-requiring herbicides |
| 07/19/2000 | EP1020524A1 Mutant bioluminescent protein and process for producing the mutant bioluminescent protein |
| 07/19/2000 | EP1020523A2 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
| 07/19/2000 | EP1020522A1 Natural human antibody |
| 07/19/2000 | EP1020521A1 Fas Ligand inhibitor ( FLINT ) compositions and uses thereof |
| 07/19/2000 | EP1020520A1 Prevention of immune related removal of cells from the mammalian body, mutant PML molecules useful therefor |
| 07/19/2000 | EP1020519A1 Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors |
| 07/19/2000 | EP1020518A1 Transporter genes |
| 07/19/2000 | EP1020517A1 Gene originating in human chondrocyte |
| 07/19/2000 | EP1020516A2 Leptospira vaccine antigens for the prevention of leptospirosis |
| 07/19/2000 | EP1020220A1 New hydrophobic polymer comprising fluorine moieties |
| 07/19/2000 | EP1019842A1 Control of nucleic acid amplification procedures including the polymerase chain reaction (pcr) |
| 07/19/2000 | EP1019724A1 Diagnostic tests and kits for clostridium difficile |
| 07/19/2000 | EP1019711A1 Methods and materials for optimization of electronic hybridization reactions |
| 07/19/2000 | EP1019696A1 Apparatus and method for transferring liquids |
| 07/19/2000 | EP1019545A1 Methods and reagents for preserving rna in cell and tissue samples |
| 07/19/2000 | EP1019543A1 Method for identifying a nucleic acid |
| 07/19/2000 | EP1019542A1 Methods to modulate blood pressure and diagnose bartter's syndrome type iii |
| 07/19/2000 | EP1019541A1 Disease association by locus stratification |
| 07/19/2000 | EP1019540A1 Efficient linking of nucleic acid segments |
| 07/19/2000 | EP1019539A1 Combinatorial antisense library |
| 07/19/2000 | EP1019538A1 Techniques for identifying, confirming, mapping and categorizing polymers |
| 07/19/2000 | EP1019537A1 Bioassay for thyroid stimulating antibodies |
| 07/19/2000 | EP1019536A1 Polymorphism detection utilizing clustering analysis |
| 07/19/2000 | EP1019535A2 Highly sensitive multimeric nucleic acid probes |
| 07/19/2000 | EP1019534A1 Multifunctional linking reagents for synthesis of branched oligomers |
| 07/19/2000 | EP1019532A1 Primers and probes for the amplification, detection and typing of mycoplasma pneumoniae |
| 07/19/2000 | EP1019529A1 A method of treating cancer |
| 07/19/2000 | EP1019526A1 Method for determining ion channel activity of a substance |
| 07/19/2000 | EP1019523A1 Apparatus and method for nucleic acid isolation using supercritical fluids |
| 07/19/2000 | EP1019522A1 Compositions and methods for administering pneumococcal dna |
| 07/19/2000 | EP1019520A1 SCREENING METHODS TO DETECT mRNA TARGETS OF EDITING ENZYMES |
| 07/19/2000 | EP1019518A1 Self-deleting vectors for cancer therapy |
| 07/19/2000 | EP1019517A2 Production of proteins in plant seeds |
| 07/19/2000 | EP1019516A1 A process for obtaining transgenic leguminous plants (leguminosae) containing exogenous dna |
| 07/19/2000 | EP1019515A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment |
| 07/19/2000 | EP1019514A1 A keratinocyte derived protease |
| 07/19/2000 | EP1019513A1 Ikr-1 and ikr-2, protein kinases which are related to the i kappa b kinases |
| 07/19/2000 | EP1019512A1 Method for producing branched fatty acids using genetically modified plants |
| 07/19/2000 | EP1019511A2 STABILIZATION OF ENVELOPE GLYCOPROTEIN TRIMERS BY DISULFIDE BONDS INTRODUCED INTO A gp41 GLYCOPROTEIN ECTODOMAIN |
| 07/19/2000 | EP1019510A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 07/19/2000 | EP1019509A2 Protein involved in abscisic acid signalling |
| 07/19/2000 | EP1019508A1 Tnf-related death ligand |
| 07/19/2000 | EP1019507A1 Amino-terminally truncated rantes as chemokine antagonists |
| 07/19/2000 | EP1019506A1 101 human secreted proteins |
| 07/19/2000 | EP1019505A1 Human hox c10 and polynucleotides encoding |
| 07/19/2000 | EP1019504A1 Isoforms of the human vitamin d receptor |
| 07/19/2000 | EP1019503A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| 07/19/2000 | EP1019502A2 Human orphan receptor ntr-1 |
| 07/19/2000 | EP1019500A2 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/19/2000 | EP1019499A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 07/19/2000 | EP1019498A1 Determination of genetic sex in equine species by analysis of y-chromosomal dna sequences |
| 07/19/2000 | EP1019497A1 Hammerhead ribozymes with extended cleavage rule |
| 07/19/2000 | EP1019496A1 In vitro sorting method |
| 07/19/2000 | EP1019495A1 Transgenic model comprising tcr alpha and beta chains |
| 07/19/2000 | EP1019491A1 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization |
| 07/19/2000 | EP1019490A2 Methods for modulating hematopoiesis and vascular growth |
| 07/19/2000 | EP1019487A1 Expression control sequences |
| 07/19/2000 | EP1019482A1 Soaps produced from high laurate canola oil-based fatty acids |
| 07/19/2000 | EP1019453A1 Aromatic-substituted xanthene dyes |
| 07/19/2000 | EP1019442A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 07/19/2000 | EP1019439A1 Soluble single-chain t-cell receptor proteins |
| 07/19/2000 | EP1019438A1 Apoptosis-related compounds and their use |
| 07/19/2000 | EP1019436A1 Acquired resistance npr genes and uses thereof |
| 07/19/2000 | EP1019435A1 Amplification of response from expressed recombinant protein |
| 07/19/2000 | EP1019432A1 The ob receptor and methods of diagnosing and treating weight |
| 07/19/2000 | EP1019431A1 Novel rnase p |
| 07/19/2000 | EP1019430A2 Automatable method for preparing samples which can be universally applied |
| 07/19/2000 | EP1019429A1 Antisense and antigene therapeutics with improved binding properties and methods for their use |
| 07/19/2000 | EP1019428A2 Inverted chimeric and hybrid oligonucleotides |
| 07/19/2000 | EP1019424A2 Reagent and method for attaching target molecules to a surface |
| 07/19/2000 | EP1019417A1 Phospholipid analogue compounds |
| 07/19/2000 | EP1019365A1 Novel compositions for the delivery of negatively charged molecules |
| 07/19/2000 | EP1019092A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 07/19/2000 | EP1019091A1 50 human secreted proteins |
| 07/19/2000 | EP1019085A1 Non-anaphylactic forms of allergens and their use |
| 07/19/2000 | EP1019084A1 Novel antimicrobial polypeptide and methods of use |
| 07/19/2000 | EP1019082A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/19/2000 | EP1019080A2 Modulation of lerk-2-mediated cell adhesion |
| 07/19/2000 | EP1019076A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 07/19/2000 | EP1019073A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP1019065A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 07/19/2000 | EP1019028A1 $i(CHLAMYDIA) PROTEIN, GENE SEQUENCE AND USES THEREOF |
| 07/19/2000 | EP1018863A1 Toxin genes from the bacteria xenorhabdus nematophilus and photorhabdus luminescens |
| 07/19/2000 | EP0923598A4 Production and use of normalized dna libraries |
| 07/19/2000 | EP0900002A4 H2-m modified transgenic animals |
| 07/19/2000 | EP0871354A4 Hypersensitive response induced resistance in plants |
| 07/19/2000 | EP0863766B1 Methods for treating injury or degeneration of photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/19/2000 | EP0527815B1 Hepatitis c virus epitopes |
| 07/19/2000 | CN1260839A Device for detecting qualitative and quantitative alterations in DNA and ligands |
| 07/19/2000 | CN1260837A Plant GRAB proteins |
| 07/19/2000 | CN1260836A Polyphenol oxidase genes from banana, tobacco and pineapple |